- Home
- RSVR vs LAB Comparison
RSVR vs LAB Comparison
Compare RSVR & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSVR
- LAB
- Stock Information
- Founded
- RSVR 2007
- LAB 1999
- Country
- RSVR United States
- LAB United States
- Employees
- RSVR N/A
- LAB N/A
- Industry
- RSVR Movies/Entertainment
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- RSVR Consumer Discretionary
- LAB Industrials
- Exchange
- RSVR Nasdaq
- LAB Nasdaq
- Market Cap
- RSVR 528.3M
- LAB 562.1M
- IPO Year
- RSVR N/A
- LAB 2011
- Fundamental
- Price
- RSVR $7.70
- LAB $1.30
- Analyst Decision
- RSVR Strong Buy
- LAB Strong Buy
- Analyst Count
- RSVR 1
- LAB 2
- Target Price
- RSVR $12.50
- LAB $2.88
- AVG Volume (30 Days)
- RSVR 29.4K
- LAB 1.8M
- Earning Date
- RSVR 02-05-2025
- LAB 02-26-2025
- Dividend Yield
- RSVR N/A
- LAB N/A
- EPS Growth
- RSVR 4113.60
- LAB N/A
- EPS
- RSVR 0.12
- LAB N/A
- Revenue
- RSVR $156,433,584.00
- LAB $155,902,000.00
- Revenue This Year
- RSVR $10.97
- LAB $62.60
- Revenue Next Year
- RSVR $6.81
- LAB $9.19
- P/E Ratio
- RSVR $66.25
- LAB N/A
- Revenue Growth
- RSVR 11.32
- LAB 48.23
- 52 Week Low
- RSVR $6.83
- LAB $1.17
- 52 Week High
- RSVR $9.83
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- RSVR 37.40
- LAB 35.51
- Support Level
- RSVR $7.28
- LAB $1.17
- Resistance Level
- RSVR $8.20
- LAB $1.51
- Average True Range (ATR)
- RSVR 0.42
- LAB 0.10
- MACD
- RSVR -0.02
- LAB 0.00
- Stochastic Oscillator
- RSVR 25.53
- LAB 32.50
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. The company's segment includes Music Publishing; Recorded Music and others. It generates the maximum of its revenue from the Music Publishing segment.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.